Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings

Abstract

Background SARS-CoV-2 can affect the human brain and other neurological structures. An increasing number of publications report neurological manifestations in patients with COVID-19. However, no studies have comprehensively reviewed the clinical and paraclinical characteristics of the central and peripheral nervous system’s involvement in these patients. This study aimed to describe the features of the central and peripheral nervous system involvement by COVID-19 in terms of pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. Methods We conducted a comprehensive systematic review of all the original studies reporting patients with neurological involvement by COVID-19, from December 2019 to June 2020, without language restriction. We excluded studies with animal subjects, studies not related to the nervous system, and opinion articles. Data analysis combined descriptive measures, frequency measures, central tendency measures, and dispersion measures for all studies reporting neurological conditions and abnormal ancillary tests in patients with confirmed COVID-19. Results A total of 143 observational and descriptive studies reported central and peripheral nervous system involvement by COVID-19 in 10,723 patients. Fifty-one studies described pathophysiologic mechanisms of neurological involvement by COVID-19, 119 focused on clinical manifestations, 4 described neuropathology findings, 62 described neuroimaging findings, 28 electrophysiology findings, and 60 studies reported cerebrospinal fluid results. The reviewed studies reflect a significant prevalence of the nervous system’s involvement in patients with COVID-19, ranging from 22.5 to 36.4% among different studies, without mortality rates explicitly associated with neurological involvement by SARS-CoV-2. We thoroughly describe the clinical and paraclinical characteristics of neurological involvement in these patients. Conclusions Our evidence synthesis led to a categorical analysis of the central and peripheral neurological involvement by COVID-19 and provided a comprehensive explanation of the reported pathophysiological mechanisms by which SARS-CoV-2 infection may cause neurological impairment. International collaborative efforts and exhaustive neurological registries will enhance the translational knowledge of COVID-19’s central and peripheral neurological involvement and generate therapeutic decision-making strategies. Registration This review was registered in PROSPERO 2020 CRD42020193140 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020193140

Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey

“…In conclusion, clinical features of FM are common in patients who recovered from symptomatic COVID-19. Preliminary evidence from clinical and preclinical studies suggests that several disease-specific mechanisms may explain the pathophysiology of this musculoskeletal syndrome, including virus-induced injury to endothelium 37 or neuromuscular structures, 38 immunological derangement and smouldering inflammation. Regarding the latter, it is interesting to note that some of the proinflammatory cytokines involved in COVID-19 and PACS manifestations, such as interleukin (IL)-1 and IL-6, 2 39 may contribute to the pathogenesis of FM.…”

SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis

“…A prevalence of the nervous system’s involvement in patients with COVID-19, ranging from 22.5 to 36.4% among different studies, has been described [ 30 ]. Neurological involvement of COVID-19 in neonates and children is still quite rare, but recent case reports document the potential neurologic involvement also in pediatric age [ 34 , 39 ].…”

“…Evidence suggests that combined direct and indirect mechanisms play a role in developing CNS and PNS involvement. As reported [ 30 ], different patho-physiological processes may be implicated such as neurotropic properties of SARS-CoV-2, damage to microvasculature, brainstem compromise, neuroinflammatory response, cytokine storm, autoimmune response, demyelination, systemic hypoxia.…”

Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy?

“…Apart from the sometimes fatal respiratory syndrome, COVID-19 leads to multi-visceral complications associated with inappropriate immune and inflammatory response [ 2 ], endothelial dysfunction and thromboembolic disorders [ 3 ]. Damage to the central and peripheral nervous system [ 4 , 5 ] was reported, including the autonomous nervous system that showed dysregulation at the early [ 6 ] and late phases of the disease [ 7 , 8 ].…”